Autoimmune haemolytic anaemia: rituximab (ESUOM39)Product type:AdviceProgramme:Evidence summaryPublished: 10 February 2015
Immune (idiopathic) thrombocytopenic purpura: rituximab (ESUOM35)Product type:AdviceProgramme:Evidence summaryPublished: 21 October 2014
Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate (ESUOM4)Product type:AdviceProgramme:Evidence summaryPublished: 29 January 2013